NCT02584387

Brief Summary

This study seeks to examine a Virtual Reality Exposure Therapy (VRET) using the 3D Video Virtual Reality (VR) technology for the fear of spiders.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 22, 2015

Completed
11 months until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

October 26, 2017

Status Verified

October 1, 2017

Enrollment Period

3 years

First QC Date

October 20, 2015

Last Update Submit

October 25, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fear of Spiders Questionnaire

    Pre-treatment and 1 week follow-up

Secondary Outcomes (7)

  • Behavioral Approach Test

    Pre-treatment and Post-treatment

  • Acceptance and Action Questionnaire

    Pre-treatment

  • State-Trait Anxiety Inventory

    Pre-treatment

  • Anxiety Sensitivity Index (ASI-3)

    Pre-treatment

  • Distress Tolerance Scale (DTS)

    Pre-treatment

  • +2 more secondary outcomes

Study Arms (2)

3D VVRET

EXPERIMENTAL

Behavioral: 3D Video Virtual Reality Exposure Therapy (VVRET) 1 30 minute 3D VRET treatment session for arachnophobia.

Behavioral: 3D Video Virtual Reality Exposure Therapy

Waitlist

NO INTERVENTION

Participants randomized to the waitlist group will complete all study procedures except the 3D VVRET. After the conclusion of their sessions, these participants will be offered the full 3D-VVRET treatment.

Interventions

The 3D video exposure therapy treatment will be administered using an oculus rift virtual reality headset. The oculus rift is a new, affordable virtual reality headset, which uses two different spherical lenses to induce a sense of stereoscopic 3D. Ortho-stereoscopic 3D refers to 3D videos that are designed to mimic the natural depth we normally see, as opposed to exaggerating it (i.e. Commercial 3D movies). To create these 3D videos, the UT 3D Department shot videos of live spiders using a stereoscopic 3D dual camera rig, which simultaneously shoots footage with two cameras positioned apart from each other in a way that mimics the natural pupillary distance between our right and left eyes. To create a sense of 3D depth, the footage of the right and left cameras is then projected on the two different lenses of the oculus rift, creating a sense of depth to the viewer through retinal disparity.

3D VVRET

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 18 and 65
  • At least one standard deviation above the SONA pool mean on Fear of Spiders Questionnaire or Acrophobia Questionnaire.

You may not qualify if:

  • Hearing or visually impaired where they cannot use the VRET gear
  • Currently (or in the last 3 months) receiving exposure-based treatment for acrophobia or arachnophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas at Austin

Austin, Texas, 78712, United States

Location

MeSH Terms

Conditions

AcrophobiaArachnophobia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate Professor

Study Record Dates

First Submitted

October 20, 2015

First Posted

October 22, 2015

Study Start

September 1, 2016

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

October 26, 2017

Record last verified: 2017-10

Locations